Description:
Topoisomerase I inhibitors used in cancer treatment.

Text:
REFERENCES 
(1) Chatterjee, K.; Zhang, J.; Honbo, N.; Karliner, J. S. Doxorubicin 
Cardiomyopathy. Cardiology 2010, 115, 155162. (2) Bodley, A.; Liu, L. F.; Israel, M.; Seshadri, R.; Koseki, Y.; Giuliani, 
F. C.; Kirschenbaum, S.; Silber, R.; Potmesil, M. DNA Topoisomerase 
IIMediated Interaction of Doxorubicin and Daunorubicin 
Congeners with DNA1. Can. Res. 1989, 49, 59695978. (3) Pommier, Y. Topoisomerase I Inhibitors Camptothecins and 
Beyond. Nat. Rev. Cancer 2006, 6, 789802. (4) Sim, S.P. ; Gatto, B.; Yu, C.; A. Liu, A.; Li, T.K. ; S. Pilch, D.; J. 
LaVoie, E.; F. Liu, L. Differential Poisoning of Topoisomerases by 
Menogaril and Nogalamycin Dictated by the Minor GrooveBinding 
Nogalose Sugar. Biochemistry 1997, 36, 1328513291.
